Stephane Culine (Stéphane Culine)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Muscle Invasive Bladder Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Karim Fizazi, Gwénaël Le Teuff, Aude Fléchon, Lance Pagliaro, Josef Mardiak, Lionnel Geoffrois, Brigitte Laguerre, Christine Chevreau, Remy Delva, Frédéric Rolland, Christine Theodore, Guilhem Roubaud, Gwenaëlle Gravis, Jean-Christophe Eymard, Mathilde Cancel, Beata Juzyna, Maria Reckova, Natacha Naoun, Christopher Logothetis, Stephane Culine
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Christian Pfister, Valentin Harter, Yves Allory, Stephane Culine, null null
Reply to S. Zeng et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Christian Pfister, Gwenaëlle Gravis, Aude Fléchon, Christine Chevreau, Hakim Mahammedi, Brigitte Laguerre, Aline Guillot, Florence Joly Lobbedez, Michel Soulié, Yves Allory, Valentin Harter, Stephane Culine, null null
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (18) (2022)